Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Europe
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. (2s,2s)-2-benzhydryl-n-(5-tert-butyl-2-methoxybenzyl)quinuclidin-3-amine Citrate Monohydrate
2. (2s,3s)-2-benzhydryl-n-(5-(tert-butyl)-2-methoxybenzyl)quinuclidin-3-amine 2-hydroxypropane-1,2,3-tricarboxylate Hydrate
3. (2s,3s)-2-benzhydryl-n-(5-tert-butyl-2-methoxybenzyl)quinuclidin-3-amine Citrate Monohydrate
4. 2-benzhydryl-n-(5-tert-butyl-2-methoxybenzyl)quinuclidin-3-amine Citrate Monohydrate
5. Maropitant
1. 359875-09-5
2. Cerenia
3. Maropitant Citrate Hydrate
4. Maropitant Citrate [usan]
5. Cj-11,972
6. Maropitant Citrate Monohydrate
7. Lxn6s3999x
8. Cj-11972
9. Maropitant Citrate (usan)
10. (2s,3s)-2-benzhydryl-n-[(5-tert-butyl-2-methoxyphenyl)methyl]-1-azabicyclo[2.2.2]octan-3-amine Citrate Hydrate
11. (2s,3s)-n-(5-(1,1-dimethylethyl)-2-methoxybenzyl)-2-(diphenylmethyl)-1-azabicyclo(2.2.2)octan-3-amine 2-hydroxy-1,2,3-propanetricarboxylate (1:1), Monohydrate
12. 1-azabicyclo(2.2.2)octan-3-amine, N-((5-(1,1-dimethylethyl)-2-methoxyphenyl)methyl)-2-(diphenylmethyl)-, (2s,3s)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1), Monohydrate
13. Unii-lxn6s3999x
14. Starbld0016570
15. Schembl4184310
16. Chembl2107353
17. Dtxsid70957411
18. Ex-a3585
19. Bs-49286
20. Maropitant Citrate Monohydrate [mi]
21. D04860
22. E83993
23. Maropitant Citrate [ema Epar Veterinary]
24. (2-benzhydryl-1-aza-bicyclo(2.2.2)oct-3-yl)-(5-tert-butyl-2-methoxybenzyl)amine
25. (2s,3s)-2-benzhydryl-n-(5-tert-butyl-2-methoxybenzyl) Quinuclidin-3-amine Citrate Monohydrate
26. (2s,3s)-2-benzhydryl-n-[(5-tert-butyl-2-methoxyphenyl)methyl]-1-azabicyclo[2.2.2]octan-3-amine;2-hydroxypropane-1,2,3-tricarboxylic Acid;hydrate
27. 2-hydroxypropane-1,2,3-tricarboxylic Acid--n-[(5-tert-butyl-2-methoxyphenyl)methyl]-2-(diphenylmethyl)-1-azabicyclo[2.2.2]octan-3-amine--water (1/1/1)
Molecular Weight | 678.8 g/mol |
---|---|
Molecular Formula | C38H50N2O9 |
Hydrogen Bond Donor Count | 6 |
Hydrogen Bond Acceptor Count | 11 |
Rotatable Bond Count | 13 |
Exact Mass | 678.35163118 g/mol |
Monoisotopic Mass | 678.35163118 g/mol |
Topological Polar Surface Area | 158 Ų |
Heavy Atom Count | 49 |
Formal Charge | 0 |
Complexity | 848 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
* Tablets:
Dogs:
- For the prevention of nausea induced by chemotherapy.
- For the prevention of vomiting induced by motion sickness.
- For the prevention and treatment of vomiting, in conjunction with Cerenia solution for injection and in combination with other supportive measures.
* Solution for injection:
Dogs:
- For the treatment and prevention of nausea induced by chemotherapy.
- For the prevention of vomiting except that induced by motion sickness.
- For the treatment of vomiting, in combination with other supportive measures.
- For the prevention of perioperative nausea and vomiting and improvement in recovery from general anaesthesia after use of the -opiate receptor agonist morphine.
Cats:
- For the prevention of vomiting and the reduction of nausea, except that induced by motion sickness.
- For the treatment of vomiting, in combination with other supportive measures.
Antiemetics
Drugs used to prevent NAUSEA or VOMITING. (See all compounds classified as Antiemetics.)
QA04AD90
Related Excipient Companies
Excipients by Applications
Market Place
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
47
PharmaCompass offers a list of Maropitant API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Maropitant manufacturer or Maropitant supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Maropitant manufacturer or Maropitant supplier.
PharmaCompass also assists you with knowing the Maropitant API Price utilized in the formulation of products. Maropitant API Price is not always fixed or binding as the Maropitant Price is obtained through a variety of data sources. The Maropitant Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Maropitant Citrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Maropitant Citrate, including repackagers and relabelers. The FDA regulates Maropitant Citrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Maropitant Citrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Maropitant Citrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Maropitant Citrate supplier is an individual or a company that provides Maropitant Citrate active pharmaceutical ingredient (API) or Maropitant Citrate finished formulations upon request. The Maropitant Citrate suppliers may include Maropitant Citrate API manufacturers, exporters, distributors and traders.
click here to find a list of Maropitant Citrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Maropitant Citrate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Maropitant Citrate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Maropitant Citrate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Maropitant Citrate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Maropitant Citrate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Maropitant Citrate suppliers with NDC on PharmaCompass.
Maropitant Citrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Maropitant Citrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Maropitant Citrate GMP manufacturer or Maropitant Citrate GMP API supplier for your needs.
A Maropitant Citrate CoA (Certificate of Analysis) is a formal document that attests to Maropitant Citrate's compliance with Maropitant Citrate specifications and serves as a tool for batch-level quality control.
Maropitant Citrate CoA mostly includes findings from lab analyses of a specific batch. For each Maropitant Citrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Maropitant Citrate may be tested according to a variety of international standards, such as European Pharmacopoeia (Maropitant Citrate EP), Maropitant Citrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Maropitant Citrate USP).